$CHTH
CNL Healthcare Properties, Inc.

2023 Q2 Form 10-Q Financial Statement

#000149645423000004 Filed on May 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $85.19M $83.66M $78.60M
YoY Change 5.12% 6.44% 9.04%
Cost Of Revenue $62.43M $61.68M $58.85M
YoY Change 3.46% 4.81% 15.56%
Gross Profit $22.75M $21.98M $19.75M
YoY Change 9.94% 11.29% -6.67%
Gross Profit Margin 26.71% 26.27% 25.12%
Selling, General & Admin $5.785M $5.720M $6.210M
YoY Change -3.0% -7.89% -7.55%
% of Gross Profit 25.43% 26.03% 31.45%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $12.60M $12.60M $12.80M
YoY Change -3.08% -1.56% 3.23%
% of Gross Profit 55.38% 57.34% 64.82%
Operating Expenses $18.65M $722.0K $807.0K
YoY Change 2392.65% -10.53% 7.17%
Operating Profit $4.107M $2.846M -$105.0K
YoY Change 389.51% -2810.48% -105.82%
Interest Expense -$9.626M -$9.188M -$3.858M
YoY Change 1183.47% 138.15% -27.24%
% of Operating Profit -234.38% -322.84%
Other Income/Expense, Net -$9.326M -$8.588M $4.518M
YoY Change 1143.47% -290.08% -14.79%
Pretax Income -$5.219M -$5.742M $4.413M
YoY Change -5964.04% -230.12% -226.16%
Income Tax $92.00K $111.0K $85.00K
% Of Pretax Income 1.93%
Net Earnings -$5.315M -$5.851M $4.303M
YoY Change -531600.0% -235.97% -300.42%
Net Earnings / Revenue -6.24% -6.99% 5.47%
Basic Earnings Per Share -$0.03 -$0.03 $0.02
Diluted Earnings Per Share -$0.03 -$0.03 $24.74K
COMMON SHARES
Basic Shares Outstanding 174.0M shares 174.0M shares 174.0M
Diluted Shares Outstanding 174.0M shares 174.0M shares 174.0M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $49.23M $43.99M $51.48M
YoY Change -25.22% -14.56% -24.69%
Cash & Equivalents $49.23M $43.99M $51.48M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $49.23M $43.99M $51.48M
YoY Change -25.22% -14.56% -24.69%
LONG-TERM ASSETS
Property, Plant & Equipment $1.295B $1.303B $1.359B
YoY Change -4.15% -4.13% -1.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $14.21M $15.66M $29.18M
YoY Change -30.99% -46.33% 64.24%
Total Long-Term Assets $1.343B $1.357B $1.403B
YoY Change -3.11% -3.29% -1.43%
TOTAL ASSETS
Total Short-Term Assets $49.23M $43.99M $51.48M
Total Long-Term Assets $1.343B $1.357B $1.403B
Total Assets $1.392B $1.401B $1.455B
YoY Change -4.11% -3.69% -2.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $28.13M $28.13M $26.97M
YoY Change 4.57% 4.3% 3.73%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $29.51M $29.57M $28.49M
YoY Change 4.22% 3.8% 2.38%
LONG-TERM LIABILITIES
Long-Term Debt $583.8M $583.7M $607.4M
YoY Change -3.95% -3.9% 1.64%
Other Long-Term Liabilities $8.330M $8.200M $7.369M
YoY Change 15.13% 11.28% -12.25%
Total Long-Term Liabilities $592.1M $591.9M $614.7M
YoY Change -3.72% -3.72% 1.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $29.51M $29.57M $28.49M
Total Long-Term Liabilities $592.1M $591.9M $614.7M
Total Liabilities $621.6M $621.4M $643.2M
YoY Change -3.37% -3.39% 1.49%
SHAREHOLDERS EQUITY
Retained Earnings $89.24M $94.56M $106.2M
YoY Change -15.94% -10.93% -13.4%
Common Stock $1.519B $1.519B $1.519B
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $769.6M $779.1M $809.8M
YoY Change
Total Liabilities & Shareholders Equity $1.392B $1.401B $1.455B
YoY Change -4.11% -3.69% -2.5%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$5.315M -$5.851M $4.303M
YoY Change -531600.0% -235.97% -300.42%
Depreciation, Depletion And Amortization $12.60M $12.60M $12.80M
YoY Change -3.08% -1.56% 3.23%
Cash From Operating Activities $11.42M $5.328M $8.236M
YoY Change -27.94% -35.31% -34.81%
INVESTING ACTIVITIES
Capital Expenditures $4.569M $2.028M -$3.579M
YoY Change -198.47% -156.66% 81.22%
Acquisitions
YoY Change
Other Investing Activities $2.620M $2.500M $0.00
YoY Change -68.07% -100.0%
Cash From Investing Activities -$1.949M $472.0K -$4.713M
YoY Change -154.67% -110.01% -186.29%
FINANCING ACTIVITIES
Cash Dividend Paid $4.453M $4.453M
YoY Change 0.0% -50.01%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $24.60M
YoY Change
Cash From Financing Activities -5.191M -$32.20M -5.090M
YoY Change 16.23% 532.53% -56.9%
NET CHANGE
Cash From Operating Activities 11.42M $5.328M 8.236M
Cash From Investing Activities -1.949M $472.0K -4.713M
Cash From Financing Activities -5.191M -$32.20M -5.090M
Net Change In Cash 4.275M -$26.40M -1.567M
YoY Change -71.38% 1584.49% -124.93%
FREE CASH FLOW
Cash From Operating Activities $11.42M $5.328M $8.236M
Capital Expenditures $4.569M $2.028M -$3.579M
Free Cash Flow $6.846M $3.300M $11.82M
YoY Change -66.57% -72.07% -19.12%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001496454
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-54685
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
CNL Healthcare Properties, Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2876363
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
CNL Center at City Commons
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
450 South Orange Avenue
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Orlando
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32801
CY2023Q1 dei City Area Code
CityAreaCode
407
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
650-1000
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
173960540 shares
CY2023Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1302979000 usd
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1313438000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43986000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
69504000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3192000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
4070000 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
38439000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
36868000 usd
CY2023Q1 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
12466000 usd
CY2022Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
13423000 usd
CY2023Q1 us-gaap Assets
Assets
1401062000 usd
CY2022Q4 us-gaap Assets
Assets
1437303000 usd
CY2023Q1 us-gaap Notes And Loans Payable
NotesAndLoansPayable
37230000 usd
CY2022Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
61773000 usd
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
546442000 usd
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
546100000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
28127000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
30270000 usd
CY2023Q1 us-gaap Other Liabilities
OtherLiabilities
8200000 usd
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
7469000 usd
CY2023Q1 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1444000 usd
CY2022Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1397000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
621443000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
647009000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 chth Excess Stock Par Or Stated Value Per Share
ExcessStockParOrStatedValuePerShare
0.01
CY2023Q1 chth Excess Stock Par Or Stated Value Per Share
ExcessStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
300000000 shares
CY2023Q1 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
300000000 shares
CY2023Q1 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
0 shares
CY2023Q1 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
0 shares
CY2023Q1 chth Excess Stock Value
ExcessStockValue
0 usd
CY2022Q4 chth Excess Stock Value
ExcessStockValue
0 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1120000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1120000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
186626000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
186626000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
173960000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
173960000 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
1740000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1740000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1516926000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1516926000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
94557000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
100408000 usd
CY2023Q1 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
833760000 usd
CY2022Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
829307000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-344000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-16000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
779119000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
789751000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
500000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
543000 usd
CY2023Q1 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
779619000 usd
CY2022Q4 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
790294000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1401062000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1437303000 usd
CY2023Q1 chth Rental Income And Related Revenues
RentalIncomeAndRelatedRevenues
6714000 usd
CY2022Q1 chth Rental Income And Related Revenues
RentalIncomeAndRelatedRevenues
6865000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
76945000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
71732000 usd
CY2023Q1 us-gaap Revenues
Revenues
83659000 usd
CY2022Q1 us-gaap Revenues
Revenues
78597000 usd
CY2023Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
57867000 usd
CY2022Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
55333000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2244000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2631000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
13410000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
13642000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
80813000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
78702000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2846000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-105000 usd
CY2023Q1 chth Interest And Other Income Expense
InterestAndOtherIncomeExpense
1066000 usd
CY2022Q1 chth Interest And Other Income Expense
InterestAndOtherIncomeExpense
5000 usd
CY2023Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
9654000 usd
CY2022Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
3863000 usd
CY2023Q1 us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss
0 usd
CY2022Q1 us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss
8376000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8588000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4518000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5742000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4413000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
111000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
85000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-5853000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
4328000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-2000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
25000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5851000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
4303000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
173960000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
173960000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
173960000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
173960000 shares
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-5853000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
4328000 usd
CY2023Q1 chth Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax Excluding Equity Method Investments
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTaxExcludingEquityMethodInvestments
-328000 usd
CY2022Q1 chth Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax Excluding Equity Method Investments
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTaxExcludingEquityMethodInvestments
876000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-328000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
876000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-6181000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
5204000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-2000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
25000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6179000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5179000 usd
CY2022Q4 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
790294000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-5853000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-328000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
41000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.0256
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
4453000 usd
CY2023Q1 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
779619000 usd
CY2021Q4 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
810761000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
4328000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
876000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.0256
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
4453000 usd
CY2022Q1 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
811512000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5328000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8236000 usd
CY2023Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
0 usd
CY2022Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
1134000 usd
CY2023Q1 chth Payment To Acquire Capital Expenditures Investing Activities
PaymentToAcquireCapitalExpendituresInvestingActivities
2028000 usd
CY2022Q1 chth Payment To Acquire Capital Expenditures Investing Activities
PaymentToAcquireCapitalExpendituresInvestingActivities
3579000 usd
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
2500000 usd
CY2022Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
472000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4713000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
4453000 usd
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
4453000 usd
CY2023Q1 us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
3128000 usd
CY2022Q1 us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
0 usd
CY2023Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
24552000 usd
CY2022Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
642000 usd
CY2023Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
41000 usd
CY2022Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-22000 usd
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
5000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-32196000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5090000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-26396000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1567000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
73574000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
57681000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
47178000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
56114000 usd
CY2023Q1 us-gaap Contribution Of Property
ContributionOfProperty
0 usd
CY2022Q1 us-gaap Contribution Of Property
ContributionOfProperty
29384000 usd
CY2023Q1 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
0 usd
CY2022Q1 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
4281000 usd
CY2023Q1 us-gaap Transfer Mortgage Payable
TransferMortgagePayable
0 usd
CY2022Q1 us-gaap Transfer Mortgage Payable
TransferMortgagePayable
18468000 usd
CY2023Q1 chth Net Assets Recognized Upon The Change In Control Of Joint Venture
NetAssetsRecognizedUponTheChangeInControlOfJointVenture
0 usd
CY2022Q1 chth Net Assets Recognized Upon The Change In Control Of Joint Venture
NetAssetsRecognizedUponTheChangeInControlOfJointVenture
15197000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:110%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:110%"> —</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated financial statements, the reported amounts of revenues and expenses during the reporting periods and the disclosure of contingent liabilities. For example, significant assumptions are made in the analysis of real estate impairments, the valuation of contingent assets and liabilities, and the valuation of restricted common stock (“Restricted Stock”) shares issued to the Advisor. Accordingly, actual results could differ from those estimates.</span>
CY2023Q1 us-gaap Variable Interest Entity Entity Maximum Loss Exposure Amount
VariableInterestEntityEntityMaximumLossExposureAmount
9100000 usd
CY2023Q1 chth Revenue Recognition Number Of Facility
RevenueRecognitionNumberOfFacility
6193 facility
CY2022Q1 chth Revenue Recognition Number Of Facility
RevenueRecognitionNumberOfFacility
6311 facility
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
76900000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
71700000 usd
CY2023Q1 chth Percentage Of Contract Related Revenue
PercentageOfContractRelatedRevenue
1.000
CY2022Q1 chth Percentage Of Contract Related Revenue
PercentageOfContractRelatedRevenue
1.000
CY2023Q1 us-gaap Land And Land Improvements
LandAndLandImprovements
136682000 usd
CY2022Q4 us-gaap Land And Land Improvements
LandAndLandImprovements
136416000 usd
CY2023Q1 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
1496933000 usd
CY2022Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
1495552000 usd
CY2023Q1 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
105953000 usd
CY2022Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
105784000 usd
CY2023Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
436589000 usd
CY2022Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
424314000 usd
CY2023Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1302979000 usd
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1313438000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
12600000 usd
CY2022Q1 us-gaap Depreciation
Depreciation
12800000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
24600000 usd
CY2023Q1 chth Debt Instrument Collateral Number Of Properties
DebtInstrumentCollateralNumberOfProperties
1 property
CY2023Q1 chth Long Term Line Of Credit Extension Option
LongTermLineOfCreditExtensionOption
P1Y
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
900000 usd
CY2023Q1 us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
3100000 usd
CY2023Q1 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
420000000 usd
CY2023Q1 us-gaap Derivative Cap Interest Rate
DerivativeCapInterestRate
0.035
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
722000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
909000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
584480000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 usd
CY2023Q1 chth Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
0 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
585389000 usd
CY2023Q1 chth Number Of Unencumbered Properties
NumberOfUnencumberedProperties
63 property
CY2023Q1 chth Financial Covenant Limitations Maximum Allowable Distributions As Percentage Of Adjusted Funds From Operations
FinancialCovenantLimitationsMaximumAllowableDistributionsAsPercentageOfAdjustedFundsFromOperations
0.95
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
807000 usd
CY2023Q1 chth Accrued General And Administrative Expenses Current
AccruedGeneralAndAdministrativeExpensesCurrent
285000 usd
CY2022Q4 chth Accrued General And Administrative Expenses Current
AccruedGeneralAndAdministrativeExpensesCurrent
238000 usd
CY2023Q1 chth Related Party Transaction Cost Of Reimbursable Expense
RelatedPartyTransactionCostOfReimbursableExpense
722000 usd
CY2022Q1 chth Related Party Transaction Cost Of Reimbursable Expense
RelatedPartyTransactionCostOfReimbursableExpense
807000 usd
CY2023Q1 chth Reimbursable Offering Expenses Due Related Party
ReimbursableOfferingExpensesDueRelatedParty
285000 usd
CY2022Q4 chth Reimbursable Offering Expenses Due Related Party
ReimbursableOfferingExpensesDueRelatedParty
238000 usd
CY2023Q1 chth Related Party Transaction Investment Services Costs
RelatedPartyTransactionInvestmentServicesCosts
0 usd
CY2022Q1 chth Related Party Transaction Investment Services Costs
RelatedPartyTransactionInvestmentServicesCosts
60000 usd
CY2023Q1 chth Due To Related Party Investment Services Fees
DueToRelatedPartyInvestmentServicesFees
0 usd
CY2022Q4 chth Due To Related Party Investment Services Fees
DueToRelatedPartyInvestmentServicesFees
0 usd
CY2023Q1 chth Related Party Transaction Asset Management Costs
RelatedPartyTransactionAssetManagementCosts
3476000 usd
CY2022Q1 chth Related Party Transaction Asset Management Costs
RelatedPartyTransactionAssetManagementCosts
3579000 usd
CY2023Q1 chth Due To Related Party Asset Management Fees
DueToRelatedPartyAssetManagementFees
1159000 usd
CY2022Q4 chth Due To Related Party Asset Management Fees
DueToRelatedPartyAssetManagementFees
1159000 usd
CY2023Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
4198000 usd
CY2022Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
4446000 usd
CY2023Q1 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1444000 usd
CY2022Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1397000 usd
CY2022Q1 chth Investment Services Fees
InvestmentServicesFees
100000 usd
CY2023Q1 chth Investment Services Fees
InvestmentServicesFees
0 usd
CY2023Q1 chth Number Of Promoted Interest Agreements
NumberOfPromotedInterestAgreements
1 agreement
CY2023Q1 chth Number Of Promoted Interest Agreements Met Established Performance Metrics
NumberOfPromotedInterestAgreementsMetEstablishedPerformanceMetrics
0 agreement

Files In Submission

Name View Source Status
0001496454-23-000004-index-headers.html Edgar Link pending
0001496454-23-000004-index.html Edgar Link pending
0001496454-23-000004.txt Edgar Link pending
0001496454-23-000004-xbrl.zip Edgar Link pending
chp-2023331x10qexhibit311.htm Edgar Link pending
chp-2023331x10qexhibit312.htm Edgar Link pending
chp-2023331x10qexhibit321.htm Edgar Link pending
chth-20230331.htm Edgar Link pending
chth-20230331.xsd Edgar Link pending
chth-20230331_g1.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
chth-20230331_cal.xml Edgar Link unprocessable
chth-20230331_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
chth-20230331_pre.xml Edgar Link unprocessable
chth-20230331_lab.xml Edgar Link unprocessable
chth-20230331_htm.xml Edgar Link completed
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending